Melatonin: A clinical perspective

Annals of Neurology

Volumn 42, Issue 4, 1997, Pages 545-553

  Penev, Plamen D ^a   Zee, Phyllis C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; NEUROPROTECTIVE AGENT;

AGING; BRAIN ISCHEMIA; CANCER; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; CLINICAL TRIAL; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; SLEEP; SLEEP DISORDER;

HUMANS; MELATONIN; MENTAL DISORDERS; NEUROIMMUNOMODULATION; PINEAL GLAND;

EID: 0030799033     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420404     Document Type: Review

References (99)

1. Arendt J. Melatonin and the mammalian pineal gland. London: Chapman and Hall, 1995
2. Brainard GC. Pineal research: the decade of transformation. J Neural Trans 1978;S13:3-10
3. Coon SL, Roseboom PH, Baler R, et al. Pineal serotonin N-acetyltransferase: expression cloning and molecular analysis. Science 1995;270:1681-1683
4. Reiter RJ. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front Neuroendocrinol 1995;16:383-415
5. Neuwelt EA, Lewy AJ. Disappearance of plasma melatonin after removal of a neoplastic pineal gland. N Eng J Med 1983;308: 1132-1135
6. Lane EA, Moss HB. Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J Clin Endocrinol Metab 1985; 61:1214-1216
7. Moore RY. The organization of the human circadian timing system. Prog Brain Res 1992;93:101-117
8. Lewy AJ, Wehr TA, Godwin FK, et al. Light suppresses melatonin secretion in humans. Science 1980;210:1267-1268
9. Trinder J, Armstrong SM, O'Brien C, et al. Inhibition of melatonin secretion onset by low levels of illumination. J Sleep Res 1996;5:77-82
10. Schiffman JS, Lasch HM, Rollag MD, et al. Effect of MR imaging on the normal human pineal body: measurement of plasma melatonin levels. J Magn Reson Imaging 1994;4:7-11
11. Selmaoui B, Lambrozo J, Touitou Y. Magnetic fields and pineal function in humans: evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms. Life Sci 1996;58:1539-1549
12. Dubocovich ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995;16:50-56
13. Reppert SM, Weaver DR. Melatonin madness. Cell 1995;83: 1059-1062
14. Carlberg C, Wiesenberg I. The orphan receptor family RZR/ ROR, melatonin and 5-lipoxygenase: an unexpected relationship. J Pineal Res 1995;18:171-178
15. Waldhauser F, Ehrhart B, Forster E. Clinical aspects of the melatonin action: impact on development, aging and puberty, involvement of melatonin in psychiatric disease and importance in neuroimmunoendocrine interactions. Experientia 1993;49: 671-681
16. Davis FC, Mannion J. Entrainment of hamster pup circadian rhythms by prenatal melatonin injections to the mother. Am J Physiol 1988;255:R439-R448
17. Kennaway DJ, Goble FC, Stamp GE. Factors influencing the development of melatonin rhythmicity in humans. J Clin Endocrinol Metab 1996;81:1525-1532
18. Illnerova H, Buresova M, Presl J. Melatonin rhythm in human milk. J Clin Endocrinol Metab 1993;77:838-841
19. Cavallo A. Melatonin and human puberty: current perspectives. J Pineal Res 1993;15:115-121
20. Takahashi JS, Hamm H, Menaker M. Circadian rhythms of melatonin release from individual superfused chicken pineal glands in vitro. Proc Natl Acad Sci USA 1980;77:2319-2322
21. Armstrong SM. Melatonin and circadian control in mammals. Experientia 1989;45:932-938
22. Lewy AJ, Sack RL, Ahmed S, et al. The influence of melatonin on the human circadian clock. In: Fraschini F, Reiter R, Stankov B, eds. The pineal gland and its hormones. New York: Plenum Press, 1995:173-182
23. Zaidan R, Geoffriau M, Brun J, et al. Melatonin is able to influence its secretion in humans: description of a phase-response curve. Neuroendocrinology 1994;60:105-112
24. McArthur AJ, Gillette MU, Prosser RA. Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res 1991;565:158-161
25. Samel A, Wegmann H-M, Vejvoda M, et al. Influence of melatonin treatment on human circadian rhythmicity before and after a simulated 9-hr time shift. J Biol Rhythms 1991;6:235-248
26. Dawson D, Encel N, Lushington K. Improving adaptation to simulated night shift: timed exposure to bright light versus day-time melatonin administration. Sleep 1995;18:11-21
27. Dahlitz M, Alvarez B, Vignau J, et al. Delayed sleep phase syndrome response to melatonin. Lancet 1991;337:1121-1124
28. Oldani A, Ferini-Strambi L, Zucconi M, et al. Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation. Neuroreport 1994;6:132-134
29. Sack RL, Lewy AJ, Blood ML, et al. Melatonin administration to blind people: phase advances and entrainment. J Biol Rhythms 1991;6:249-261
30. Palm L, Blennow G, Wetterberg L. Correction of non-24-hour sleep/wake cycle by melatonin in a blind retarded boy. Ann Neurol 1991;29:336-339
31. McArthur AJ, Lewy AJ, Sack RL. Non-24-hour sleep-wake syndrome in a sighted man: circadian rhythm studies and efficacy of melatonin treatment. Sleep 1995;19:544-553
32. Tzischinsky O, Lavie P. Melatonin possesses time-dependent hypnotic effects. Sleep 1994;17:638-645
33. Tzischinsky O, Shlitner A, Lavie P. The association between nocturnal sleep gates and nocturnal onset of urinary aMT6s. J Biol Rhythms 1994;8:199-209
34. Nakagawa H, Sack RL, Lewy AJ. Sleep propensity free-runs with the temperature, melatonin and cortisol rhythms in a totally blind person. Sleep 1992;15:330-336
35. Lockley S, Tabandeh H, Skene D, et al. Day-time naps and melatonin in blind people. Lancet 1995;346:1491 (Letter)
36. Etzioni A, Luboshitzky R, Tiosano D, et al. Melatonin replacement corrects sleep disturbances in a child with pineal tumor. Neurology 1996;46:261-263
37. Lehmann ED, Cockerell OC, Rudge P. Somnolence associated with melatonin deficiency after pinealectomy. Lancet 1996;347: 323 (Letter)
38. Czeisler CA, Turek FW. Is melatonin a treatment for insomnia? National Sleep Foundation Publication. Washington, DC, 1997
39. Dawson D, Encel N. Melatonin and sleep in humans. J Pineal Res 1993;15:1-12
40. Dollins AB, Zhdanova IV, Wurtman RJ, et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature and performance. Proc Natl Acad Sci USA 1994;91:1824-1828
41. Dijk D-J, Roth C, Landolt H-P, et al. Melatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity. Neurosci Lett 1995;201:13-16
42. Cajochen C, Krauchi K, von Arx MA, et al. Daytime melatonin administration enhances sleepiness and theta/alpha activity in the waking EEG. Neurosci Lett 1996;207:209-213
43. Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57:552-558
44. James SP, Mendelson WB, Sack DA, et al. The effects of melatonin on normal sleep. Neuropsychopharmacology 1987;1: 41-44
45. Waldhauser F, Saletu B, Lugan IT. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology 1990;100:222-226
46. MacFarlane JG, Cleghorn JM, Brown GM, Streiner DL. The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study. Biol Psychiatry 1991;30:371-376
47. James SP, Sack DA, Rosenthal NE, Mendelson WB. Melatonin administration in insomnia. Neuropsychopharmacology 1990;3: 19-23
48. Ellis CM, Lemmens G, Parkes JD. Melatonin and insomnia. J Sleep Res 1996;5:61-65
49. Jan JE, Espezel H. Melatonin treatment of chronic sleep disorders. Dev Med Child Neurol 1995;37:279-280
50. Camfield P, Gordon K, Dooley J, Camfield C. Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trials. J Child Neurol 1996;11:341-343
51. Haimov I, Lavie P, Laudon M, et al. Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18:598-603
52. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995;346:541-544
53. Wurtman RJ, Zhdanova I. Improvement of sleep quality by melatonin. Lancet 1995;346:1491 (Letter)
54. Wehr TA, Moul DE, Barbato G, et al. Conservation of photoperiod-responsive mechanisms in humans. Am J Physiol 1993;265:R846-R857
55. Wehr TA, Giesen HA, Moul DE, et al. Suppression of men's response to seasonal changes in day length by modern artificial lighting. Am J Physiol 1995;269:R173-R178
56. Vaughan GM. Melatonin in humans. Pineal Res Rev 1984;2: 141-201
57. Li Y, Jiang DH, Wang ML, et al. Rhythms of serum melatonin in patients with spinal lesion at the cervical, thoracic or lumbar region. Clin Endocrinol 1989;30:47-56
58. Tetsuo M, Polinsky RJ, Markey SP, Kopin IJ. Urinary 6-hydroxy-melatonin excretion in patients with orthostatic hypotension. J Clin Endocrinol Metab 1981;53:607-610
59. O'Brien IA, Lewin IG, O'Hare JP, et al. Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy. Clin Endocrinol 1986;24:359-364
60. Fiorina P, Lattuada G, Ponari O, et al. Impaired nocturnal melatonin excretion and changes of immunological status in ischemic stroke patients. Lancet 1996;347:692-693
61. Pang SF, Li Y, Jiang DH, et al. Acute cerebral hemorrhage changes the nocturnal surge of plasma melatonin in humans. J Pineal Res 1990;9:193-208
62. Yamada N, Iwasa H, Mori S, et al. Melatonin secretion in normal pressure hydrocephalus after cerebral aneurysm rupture -investigation before and after ventriculoperitoneal shunt. Neurol Med Chir (Tokyo) 1991;31:490-497
63. Ekman AC, Leppaluoto J, Huttunen P, et al. Ethanol inhibits melatonin secretion in healthy volunteers in a dose-dependent randomized double blind cross-over study. J Clin Endocrinol Metab 1993;7:780-783
64. Wikner J, Andersson DEH, Wetterberg L, Rojdmark S. Impaired melatonin secretion in patients with Wernicke-Korsakoff syndrome. J Int Med 1995;37:571-575
65. Laakso ML, Leinonen L, Hatonen T, et al. Melatonin, cortisol and body temperature rhythms in Lennox-Gastaut patients with or without circadian rhythm sleep disorders. J Neurol 1993;40: 410-416
66. 2+ epileptiform activity in human temporal slices. Exp Brain Res 1995;107:321-325
67. Uchida K, Okamoto N, Ohara K, Morita Y. Daily rhythm of serum melatonin in patients with dementia of the degenerative type. Brain Res 1996;717:154-159
68. Reiter RJ, Barlow-Walden L, Poeggeler B, et al. Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects. J Pineal Res 1996;20:45-50
69. Fertl E, Auff E, Doppelbauer A, Waldhauser F. Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of 1-dopa. J Neural Transm 1993;5:227-234
70. Shaw KM, Stern GM, Sandler M. Melatonin and parkinsonism. Lancet 1973;1:271
71. Cagnoli CM, Atabay C, Kharlamova E, Manev H. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995;18:222-226
72. Giusti P, Franceschini D, Petrone M, et al. In vitro and in vivo protection against kainate-induced excitotoxicity by melatonin. J Pineal Res 1996;20:226-231
73. Bertuglia S, Marchiafava PL, Colantuoni A. Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 1996;31:947-952
74. Manev H, Uz T, Kharlamov A, Joo JY. Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J 1996;10:1546-1551
75. Cagnacci A, Elliott JA, Yen SSC. Melatonin: a major regulator of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab 1992;75:447-452
76. Capsoni S, Stankov BM, Fraschini F. Reduction of regional blood flow by melatonin in young rats. Neuroreport 1995;6: 1346-1348
77. Mortola JF, Laughlin GA, Yen SS. Melatonin rhythms in women with anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 1993;77:1540-1544
78. Wehr TA, Jacobsen FM, Sack DA, et al. Phototherapy of seasonal affective disorder. Time of day and suppression of melatonin are not critical for antidepressant effects. Arch Gen Psychiatry 1986;43:870-875
79. Wirz-Justice A, Graw P, Krauchi K, et al. Light therapy in seasonal affective disorder is independent of time of day or circadian phase. Arch Gen Psychiatry 1993;50:929-937
80. Tapp E. The histology and pathology of the human pineal gland. Prog Brain Res 1979;52:481-500
81. Iguchi H, Kato KI, Ibayashi H. Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab 1982;54:1025-1027
82. Steindl PE, Finn B, Bendok B, et al. Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann Intern Med 1995;123:274-277
83. Viljoen M, Steyn ME, Van Rensburg BW, Reinach SG. Melatonin in chronic renal failure. Nephron 1992;60:138-143
84. Brugger P, Marktl W, Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995;345:1408
85. Viswanathan M, Laitinen JT, Saavedra JM. Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci USA 1990;87:6200-6203
86. Birau N, Reterssen U, Meyer C, Gottschalk J. Hypotensive effects of melatonin in essential hypertension. IRCS Med Sci 1981;9:906
87. Gonzales-Haba MG, Garcia-Maurino S, Calvo JR, et al. High-affinity binding of melatonin by human circulating T lymphocytes (CD4+). FASEB J 1995;9:1331-1335
88. Maestroni GJ. The immunoneuroendocrine role of melatonin. J Pineal Res 1993;14:1-10
89. Steinhilber D, Brungs M, Werz O, et al. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem 1995;270:7037-7040
90. Bartsch C, Bartsch H, Lippert TH. The pineal gland and cancer: facts, hypotheses and perspectives. Cancer J 1992;5: 194-199
91. Tamarkin L, Cohen M, Rosello D, et al. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenzantracene-induced mammary tumors in the rat. Cancer Res 1981;41: 4432-4436
92. Cohen M, Lippman M, Chabner B. Role of pineal gland in aetiology and treatment of breast cancet. Lancet 1978;11:814-816
93. Lemus-Wilson A, Kelly PA, Blask DE. Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. Br J Cancer 1995;72:1435-1440
94. Lissoni P, Barni S, Meregalli S, et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 1995;71:854-856
95. Reiter RJ. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol 1995; 30:199-212
96. Huether G. Melatonin as an antiaging drug: between facts and fantasy. Gerontology 1996;42:87-96
97. Pierpaoli W, Regelson W. Pineal control of aging: effects of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci USA 1994;91:787-791
98. Oaknin-Bendahan S, Anis Y, Nir I, Zisapel N. Effects of long-term administration of melatonin and a putative antagonist on the ageing rat. Neuroreport 1995;6:785-788
99. Turek FW. Melatonin hype hard to swallow. Nature 1996;379: 295-296